Cargando…

Fibroblast Growth Factor 23 and Muscle Wasting: A Metabolic Point of View

Protein energy wasting (PEW), mostly characterized by decreased body stores of protein and energy sources, particularly in the skeletal muscle compartment, is highly prevalent in patients with moderate to advanced chronic kidney disease (CKD). Fibroblast growth factor 23 (FGF23) is an endocrine horm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elsurer Afsar, Rengin, Afsar, Baris, Ikizler, Talat Alp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334408/ https://www.ncbi.nlm.nih.gov/pubmed/37441473 http://dx.doi.org/10.1016/j.ekir.2023.04.027

Ejemplares similares

Hypoxia inducible factor-1 protects against COVID-19: A hypothesis
por: Afsar, Baris, et al.
Publicado: (2020)

Air pollution and kidney disease: review of current evidence
por: Afsar, Baris, et al.
Publicado: (2018)

Capillary rarefaction from the kidney point of view
por: Afsar, Baris, et al.
Publicado: (2018)

Sodium–glucose cotransporter inhibition in polycystic kidney disease: fact or fiction
por: Afsar, Baris, et al.
Publicado: (2022)

Sweet dreams: therapeutic insights, targeting imaging and physiologic evidence linking sleep, melatonin and diabetic nephropathy
por: Afsar, Baris, et al.
Publicado: (2020)

Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009)

The Relationship Between Erythropoietin Resistance and Antibody Response to Hepatitis B Vaccine in Hemodialysis Patients
por: Afsar, Baris
Publicado: (2013)

Do We Have to Shift Three Doses of Hepatitis B Vaccine Instead of Four Doses in Chronic Renal Failure: Think Before Action
por: Afsar, Baris
Publicado: (2013)

The Impact of Different Anthropometric Measures on Sustained Normotension, White Coat Hypertension, Masked Hypertension, and Sustained Hypertension in Patients with Type 2 Diabetes
por: Afsar, Baris
Publicado: (2013)

Microalbuminuria, Kidney Function, and Daily Physical Activity
por: Afsar, Baris
Publicado: (2013)

Pathophysiology of copeptin in kidney disease and hypertension
por: Afsar, Baris
Publicado: (2017)

The relationship between insulin, insulin resistance, parathyroid hormone, cortisol, testosterone, and thyroid function tests in the presence of nephrolithiasis: a comprehensive analysis
por: Afsar, Baris, et al.
Publicado: (2014)

The relationships between cortisol levels, insulin levels, and thyroid hormones with 24-h urinary sodium excretion in never treated essential hypertensive patients
por: Afsar, Baris, et al.
Publicado: (2014)

3577 Adiposity and Fibroblast Growth Factor 23 in nondiabetic patients with moderate-to-severe Chronic Kidney Disease
por: Akwo, Elvis, et al.
Publicado: (2019)

Fibroblast growth factor 23 and bone mineralisation
por: Guo, Yu-Chen, et al.
Publicado: (2015)

Physiological Actions of Fibroblast Growth Factor-23
por: Erben, Reinhold G.
Publicado: (2018)

Upstream Regulators of Fibroblast Growth Factor 23
por: Ratsma, Danielle M. A., et al.
Publicado: (2021)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Fibroblast growth factor 23, klotho and heparin
por: Thomas, S. Madison, et al.
Publicado: (2023)

Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer
por: Ghorbanihaghjo, Amir, et al.
Publicado: (2018)

Acute Kidney Injury and Advanced Kidney Disease in the COVID-19 Pandemic: Proceedings From a National Kidney Foundation Symposium
por: Hirsch, Jamie S., et al.
Publicado: (2021)

Wasting in chronic kidney disease
por: Mak, Robert H., et al.
Publicado: (2011)

PKC regulates the production of fibroblast growth factor 23 (FGF23)
por: Bär, Ludmilla, et al.
Publicado: (2019)

The Measurement and Interpretation of Fibroblast Growth Factor 23 (FGF23) Concentrations
por: Heijboer, Annemieke C., et al.
Publicado: (2022)

A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway
por: Wang, Joseph, et al.
Publicado: (2017)

Erratum to: Wasting in chronic kidney disease
por: Mak, Robert H., et al.
Publicado: (2011)

Relationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease
por: Nitta, Kosaku
Publicado: (2010)

The effects of maternal iron deficiency on infant fibroblast growth factor-23 and mineral metabolism
por: Braithwaite, V.S., et al.
Publicado: (2016)

The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function
por: Vergara, Noemi, et al.
Publicado: (2022)

The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management?
por: Cozzolino, Mario, et al.
Publicado: (2020)

Fibroblast Growth Factor–23 and Cardiac Structure and Function
por: Agarwal, Isha, et al.
Publicado: (2014)

The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
por: Czaya, Brian, et al.
Publicado: (2019)

Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23)
por: Feger, Martina, et al.
Publicado: (2021)

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
por: Ewendt, Franz, et al.
Publicado: (2021)

Ascorbic acid: a promising agent in chronic kidney disease?
por: Karahan, Salih, et al.
Publicado: (2018)

The Gut Microbiota Regulates Endocrine Vitamin D Metabolism through Fibroblast Growth Factor 23
por: Bora, Stephanie A., et al.
Publicado: (2018)

Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018)

Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis
por: Honda, Hirokazu, et al.
Publicado: (2020)

Skeletal muscle energetics in patients with moderate to advanced kidney disease
por: Ertuglu, Lale, et al.
Publicado: (2022)

Iron status and fibroblast growth factor-23 in Gambian children
por: Braithwaite, Vickie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i21j6ub43d4snnouqcv92eial5